Smedi Co (XKRX:118000) Change In Receivables : ₩-2,085 Mil (TTM As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Smedi Co Change In Receivables?

Smedi Co's change in receivables for the quarter that ended in Mar. 2024 was ₩4,978 Mil. It means Smedi Co's Accounts Receivable declined by ₩4,978 Mil from Dec. 2023 to Mar. 2024 .

Smedi Co's change in receivables for the fiscal year that ended in Dec. 2023 was ₩-7,122 Mil. It means Smedi Co's Accounts Receivable increased by ₩7,122 Mil from Dec. 2022 to Dec. 2023 .

Smedi Co's Accounts Receivable for the quarter that ended in Mar. 2024 was ₩7,047 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Smedi Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 131.59.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Smedi Co's liquidation value for the three months ended in Mar. 2024 was ₩39,245 Mil.

Smedi Co Change In Receivables Historical Data

The historical data trend for Smedi Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Smedi Co Change In Receivables Chart

Smedi Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

2,155.15

986.66

4,259.56

-778.04

-7,121.59

Smedi Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-58.68	929.57	2,205.58	-10,198.06	4,978.20

Smedi Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-2,085 Mil.

Smedi Co (XKRX:118000) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Smedi Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	7046.892	/	4886.45	*	91
=	131.59

2. In Ben Graham's calculation of liquidation value, Smedi Co's accounts receivable are only considered to be worth 75% of book value:

Smedi Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	36981.386	-	3545.413	+	0.75 * 7046.892	+	0.5 * 1047.117
=	39,245

Smedi Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Smedi Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Smedi Co (XKRX:118000) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Smedi Co Ltd (XKRX:118000) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

202, 156, Byeongjeomjungang-ro, Jinan-dong, Dream Buildiing, Gyeonggi-do, Hwaseong-si, KOR

Website

http://www.themp.co.kr

Smedi Co Ltd, formerly The Medipharm Co Ltd has established a hospital in Jeju and exports various types of medical equipments. The company also built its own hospital in China and India and plans to expand its business in Spain and Dubai. The Company and its subsidiaries are divided into pharmaceutical business, medical business, wireless device business, investment and others according to business characteristics by business sector.

Smedi Co (XKRX:118000) Headlines

No Headlines